Daniel R. Chevallard Graphite Bio, Inc. (GRPH) insider trading activity

GRPH Quotes by TradingView

Daniel R. Chevallard is Chief Financial Officer of Graphite Bio, Inc.. Currently has a direct ownership of 5,386 shares of GRPH, which is worth approximately $0. The most recent transaction as insider was on Nov 07, 2025, when has been sold 2,198 shares (Common Stock) at a price of $22.74 per share, resulting in proceeds of $49,982. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.39K
68.95% 3M change
68.95% 12M change
Total Value Held $0

Daniel R. Chevallard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2025
BUY
Open market or private purchase
$49,982 $22.74 p/Share
2,198 Added 28.98%
5,386 Common Stock
May 14 2024
BUY
Open market or private purchase
$49,987 $15.68 p/Share
3,188 Added 50.0%
3,188 Common Stock

Also insider at

VIRX
Viracta Therapeutics, Inc. Healthcare
CFO and COO
DRC

Daniel R. Chevallard

Chief Financial Officer
Cardiff, CA

Track Institutional and Insider Activities on GRPH

Follow Graphite Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRPH shares.

Notify only if

Insider Trading

Get notified when an Graphite Bio, Inc. insider buys or sells GRPH shares.

Notify only if

News

Receive news related to Graphite Bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GRPH